GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » Market Cap

Medicofarma Biotech (WAR:MDB) Market Cap : zł53.02 Mil (As of May. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medicofarma Biotech's share price for the quarter that ended in Mar. 2024 was zł0.95. Medicofarma Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 67.98 Mil. Therefore, Medicofarma Biotech's market cap for the quarter that ended in Mar. 2024 was zł64.58 Mil.

Medicofarma Biotech's quarterly market cap increased from Jun. 2023 (zł70.36 Mil) to Sep. 2023 (zł81.57 Mil) but then declined from Sep. 2023 (zł81.57 Mil) to Mar. 2024 (zł64.58 Mil).

Medicofarma Biotech's annual market cap increased from Dec. 2020 (zł19.81 Mil) to Dec. 2021 (zł115.56 Mil) but then declined from Dec. 2021 (zł115.56 Mil) to Dec. 2022 (zł78.51 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medicofarma Biotech's Enterprise Value for Today is zł52.96 Mil.


Medicofarma Biotech Market Cap Historical Data

The historical data trend for Medicofarma Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech Market Cap Chart

Medicofarma Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 2.10 19.81 115.56 78.51

Medicofarma Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.51 69.68 70.36 81.57 64.58

Competitive Comparison of Medicofarma Biotech's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicofarma Biotech's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's Market Cap falls into.



Medicofarma Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Medicofarma Biotech's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=zł1.155*67.9783
=zł78.51

Medicofarma Biotech's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=zł0.95*67.9783
=zł64.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicofarma Biotech  (WAR:MDB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Medicofarma Biotech Market Cap Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicofarma Biotech (WAR:MDB) Business Description

Traded in Other Exchanges
N/A
Address
ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.